Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancer

Jiayun Li1, Philip Moresco1,2,3, Douglas T Fearon1,4

  • 1Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724.

Insights

Natural killer T (NKT) cells are crucial for an active anti-tumor immune response in pancreatic ductal adenocarcinoma (PDA). Boosting NKT cells enhances immunotherapy effectiveness against this lethal cancer.

Area of Science:

  • Immunology
  • Oncology

Background:

  • Pancreatic ductal adenocarcinoma (PDA) is a lethal cancer with limited treatment options.
  • The immunosuppressive tumor microenvironment (TME) hinders effective anti-cancer immunity and immunotherapy response.
  • Understanding the immune dynamics within the PDA TME is critical for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of natural killer T (NKT) cells in shaping the immune landscape of the PDA TME.
  • To elucidate the mechanisms by which NKT cells influence anti-tumor immunity in PDA.
  • To explore the therapeutic potential of targeting NKT cells for PDA treatment.

Main Methods:

  • Utilized a mouse model of pancreatic ductal adenocarcinoma (sgKRT19-edited).
  • Analyzed the composition and function of immune cells within the tumor microenvironment.
  • Investigated molecular interactions between NKT cells and myeloid cells (CD40L-CD40).
  • Assessed the therapeutic efficacy of folinic acid combined with anti-PD-1 antibody treatment.

Main Results:

  • Intratumoral accumulation of NKT cells was essential for an immunologically active PDA TME.
  • NKT cells promoted type I interferon (IFN) production, initiating adaptive anti-tumor immunity.
  • NKT cells orchestrated the infiltration of various immune cells, including T cells, dendritic cells, and NK cells.
  • NKT cell-mediated type I IFN production involved CD40L-CD40 interactions with myeloid cells.
  • Folinic acid administration increased intratumoral NKT cells and enhanced anti-PD-1 therapy response in mice.

Conclusions:

  • NKT cells play a pivotal role in mediating immune responses against mouse PDA.
  • NKT cells are a promising therapeutic target for enhancing immunotherapy in pancreatic cancer.
  • Modulating NKT cell activity represents a potential strategy to overcome immune evasion in PDA.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K